You are here

  • Home
  • Archive
  • Volume 88, Issue 3
  • Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy

Article info

Article menu
Download PDFPDF
Editorial
Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy

Authors

  1. Correspondence to Dr Paddy J Horner, School of Social and Community Medicine, University of Bristol, 39 Whatley Road, Bristol BS8 2PS, UK; paddy.horner{at}bristol.ac.uk
View Full Text

Citation

Horner PJ
Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy
Sexually Transmitted Infections 2012;88:154-156.

Publication history

  • Accepted February 20, 2012
  • First published March 13, 2012.
Online issue publication 
May 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.